UBS Group’s BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock PHGE.U Stock Holding History

UBS Group’s Portfolio PHGE.U Stock Details PHGE.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-97	Closed	-$126	–	10710
2024 Q3	$126	Buy	97 +93	+2,325%	+$186	﹤0.01%	9133
2024 Q2	$11	Hold	4	–	–	﹤0.01%	9352
2024 Q1	$10	Buy	+4	New	+$13	﹤0.01%	9104
2023 Q1	–	Sell	-35	Closed	-$78	–	10683
2022 Q4	$78	Hold	35	–	–	﹤0.01%	10432
2022 Q3	$0	Buy	35 +10	+40%	+$90	﹤0.01%	11127
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	10029
2022 Q1	$1K	Hold	25	–	–	﹤0.01%	9970
2021 Q4	$1K	Hold	25	–	–	﹤0.01%	10060
2021 Q3	$1K	Buy	25 +10	+67%	+$663	﹤0.01%	9279
2021 Q2	$1K	Buy	+15	New	+$1.29K	﹤0.01%	9211

UBS Group's PHGE.U Position: Q4 2024 in Review

UBS Group sold out of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) in Q4 2024, closing a stake of 97 shares — an estimated $126 sold.

UBS Group first reported a position in PHGE.U in Q2 2021 and held it in 10 quarters. The position peaked at $1K in Q2 2022. 0 funds tracked by Wall St. Rank hold PHGE.U as of Q4 2024.

UBS Group reported no remaining BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position as of Q4 2024 after selling out during the quarter.
UBS Group sold 97 BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock shares in Q4 2024, an estimated $126.
UBS Group first reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in Q2 2021 and held it in 10 quarters.
UBS Group's BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position peaked at $1K in Q2 2022.
0 funds tracked by Wall St. Rank held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.